Eyal Flom
Net worth: 113 648 $ as of 31/05/2026
Net worth: 113 648 $ as of 31/05/2026
Eyal Flom currently serves as Secretary, Director & General Counsel at InnoCan Pharma Corp.
since 2020, Director at NurExone Biologic Ltd., and Legal Counsel at the Israeli Pharmaceutical Association since 1995.
Former positions include Director at NurExone Biologic, Inc. from 2020 to 2022 and Director at Revium Recovery, Inc. from 2021 to 2024.
Education includes an MBA from the University of Derby and graduate studies at Tel-Aviv University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/07/2025 | 42,014 ( 0.93% ) | 113 648 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| INNOCAN PHARMA CORPORATION | Director/Board Member | 25/09/2019 |
Israeli Pharmaceutical Association | General Counsel | 01/04/1995 |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| REVIUM RX. | Director/Board Member | 01/12/2024 |
| NUREXONE BIOLOGIC INC. | Director/Board Member | 01/05/2022 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Revium Recovery, Inc.
Revium Recovery, Inc. Food DistributorsDistribution Services Distributes alcoholic and non-alcoholic beverages | Distribution Services |
University of Derby
University of Derby Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InnoCan Pharma Corp.
InnoCan Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Israeli Pharmaceutical Association | Commercial Services |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
Select your edition
All financial news and data tailored to specific country editions